EWA
CRDF icon

Evolution Wealth Advisors’s Cardiff Oncology CRDF Stock Holding History

Evolution Wealth Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-429
Closed -$3K – 262
2021
Q3 		$3K Sell
429
-381
-47% -$2.39K ﹤0.01% 598
2021
Q2 		$5K Hold
810
– – ﹤0.01% 503
2021
Q1 		$8K Buy
810
+297
+58% +$3.61K ﹤0.01% 448
2020
Q4 		$9K Buy
+513
New +$9.02K ﹤0.01% 356

Other funds holding CRDF

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Evolution Wealth Advisors's CRDF Position: Q4 2021 in Review

Evolution Wealth Advisors sold out of Cardiff Oncology (CRDF) in Q4 2021, closing a stake of 429 shares — an estimated $3K sold.

Evolution Wealth Advisors first reported a position in CRDF in Q4 2020 and held it in 4 quarters. The position peaked at $9K in Q4 2020. 87 funds tracked by Wall St. Rank hold CRDF as of Q4 2021.

  • Evolution Wealth Advisors reported no remaining Cardiff Oncology position as of Q4 2021 after selling out during the quarter.
  • Evolution Wealth Advisors sold 429 Cardiff Oncology shares in Q4 2021, an estimated $3K.
  • Evolution Wealth Advisors first reported a position in Cardiff Oncology in Q4 2020 and held it in 4 quarters.
  • Evolution Wealth Advisors's Cardiff Oncology position peaked at $9K in Q4 2020.
  • 87 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2021.

Based on Evolution Wealth Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.